Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-23-003333
Filing Date
2023-03-09
Accepted
2023-03-09 16:33:22
Documents
6
Effectiveness Date
2023-03-09

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20230309xs8.htm S-8 87092
2 EX-5.1 tmb-20230309xex5d1.htm EX-5.1 13816
3 EX-23.1 tmb-20230309xex23d1.htm EX-23.1 4025
4 EX-FILING FEES tmb-20230309xexfilingfees.htm EX-FILING FEES 26521
5 GRAPHIC tmb-20230309xex5d1001.jpg GRAPHIC 3668
6 GRAPHIC tmb-20230309xex5d1002.jpg GRAPHIC 3677
  Complete submission text file 0001558370-23-003333.txt   142888
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270413 | Film No.: 23720203
SIC: 2834 Pharmaceutical Preparations